Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
LSI, IKP, Genome valley, Hyderabad, Shamirpet, Telangana, 506167, IN
The two companies have collaborated on other fronts since 2021.
By: Patrick Lavery
The company hopes to bridge spatial biomarker discovery and clinical translation.
A first-of-its-kind integration of a clinically validated cancer prediction AI is at the heart of the partnership.
The Chai-3 model aims to help accelerate drug discovery research.
By: Charlie Sternberg
Huang brings 25+ years of leadership experience across the pharmaceutical and CDMO sectors.
Why analytical method performance depends not only on sample size, but on a lifecycle-based control strategy that understands uncertainty, variability, and risk.
By: Paul Mason
To offer and distribute Dow's Decarbia low-carbon products across key markets.
By: Kristin Brooks
Successfully tech-transferred and manufactured first commercial-scale GMP batches of Renaissance Pharma’s lead candidate, Daretabart.
Mr. Wang will spearhead the integration of computational science and data-driven decision-making across the R&D operation.
De Ganck will help ensure Ardena’s scientific expertise is effectively aligned across services and sites.
Licensing and research collaboration covers up to five programs with potential milestone payments nearing $3 billion.
Natera’s Signatera test will be used to longitudinally assess response in patients enrolled in Diakonos’ Phase I/II investigational trial.
Aims to boost clinical supply and commercialization readiness for Ratio’s lead radiopharmaceutical therapy.
Margin compression, tariff exposure, and supplier consolidation are piling pressure on contract manufacturers. But single-use technology redrew the competitive landscape and a second wave in cell and gene therapy is doing it again.
By: Dan Stanton
This marks the latest indication in oncology for Imfinzi nine years after the drug’s first approval.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
